Agios Pharmaceuticals(NASDAQ: AGIO) stock rose by 13.8% during the week through Friday morning. It's a move driven by the ...

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for SL1009 ...

New research finds that birds can use lactate, often thought of as a metabolic waste product, as a cellular fuel that aids in ...

Agios Pharmaceuticals shares rose Tuesday after the U.S. Food and Drug Administration granted priority review to the company's supplemental new drug application for mitapivat to treat sickle cell ...

Agios Pharmaceuticals (AGIO) stock rises as the U.S. FDA grants priority review for the company's bid to seek a label ...

Agios stock jumps after the FDA accepts and grants priority review to its sNDA for mitapivat in sickle cell disease, with a ...

Fibromyalgia is a painful syndrome that also affects the psyche. Fortunately, improving the gut microbiome can significantly ...

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...

For doctors around the world, Alessandro is almost a miracle: he is the first patient affected by an extremely rare metabolic ...

Make time for AWP presents The Improv Maniacs Show, A Family Friendly Night of LAUGHS! on the Roswell Patch calendar ...